Background: Artemisia species are important medicinal plants throughout the world. The present in vitrostudy, using a sesquiterpene lactone-bearing fraction prepared from Artemisia khorassanica (SLAK), sought toinvestigate anti-cancer properties of this plant and elucidate potential underlying mechanisms for the effects.Materials and Methods: Anti-cancer potential was evaluated by toxicity against human melanoma and fibroblastcell lines. To explore the involved pathways, pattern of any cell death was determined using annexin-V/PI stainingand also the expression of Bax and cytochrome c was investigated by Western blotting. Results: The resultsshowed that SLAK selectively caused a concentration-related inhibition of proliferation of melanoma cells thatwas associated with remarkable increase in early events and over-expression of both Bax and cytochrome c. Conclusions: The current experiment indicates that Artemisia may have anti-cancer activity. We anticipate thatthe ingredients may be employed as therapeutic candidates for melanoma.
(2015). Anti-cancer Properties of a Sesquiterpene Lactone-bearing Fraction from Artemisia khorassanica. Asian Pacific Journal of Cancer Prevention, 16(3), 863-868.
MLA
. "Anti-cancer Properties of a Sesquiterpene Lactone-bearing Fraction from Artemisia khorassanica". Asian Pacific Journal of Cancer Prevention, 16, 3, 2015, 863-868.
HARVARD
(2015). 'Anti-cancer Properties of a Sesquiterpene Lactone-bearing Fraction from Artemisia khorassanica', Asian Pacific Journal of Cancer Prevention, 16(3), pp. 863-868.
VANCOUVER
Anti-cancer Properties of a Sesquiterpene Lactone-bearing Fraction from Artemisia khorassanica. Asian Pacific Journal of Cancer Prevention, 2015; 16(3): 863-868.